Lessee, Operating Lease, Liability, to be Paid in USD of Eiger BioPharmaceuticals, Inc. from Q4 2018 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Eiger BioPharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and change rate from Q4 2018 to Q3 2023.
  • Eiger BioPharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending 30 Sep 2023 was $209K, a 26.4% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

Eiger BioPharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2023 $209K -$75K -26.4% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $334K -$117K -25.9% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $460K -$158K -25.6% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $613K -$169K -21.6% 31 Dec 2022 10-K 17 Mar 2023
Q3 2022 $284K -$654K -69.7% 30 Sep 2022 10-Q 03 Nov 2022
Q2 2022 $451K -$650K -59% 30 Jun 2022 10-Q 04 Aug 2022
Q1 2022 $618K -$671K -52.1% 31 Mar 2022 10-Q 05 May 2022
Q4 2021 $782K -$667K -46% 31 Dec 2021 10-K 10 Mar 2022
Q3 2021 $938K -$670K -41.7% 30 Sep 2021 10-Q 04 Nov 2021
Q2 2021 $1.1M -$665K -37.7% 30 Jun 2021 10-Q 05 Aug 2021
Q1 2021 $1.29M -$680K -34.5% 31 Mar 2021 10-Q 06 May 2021
Q4 2020 $1.45M -$676K -31.8% 31 Dec 2020 10-K 09 Mar 2021
Q3 2020 $1.61M -$548K -25.4% 30 Sep 2020 10-Q 05 Nov 2020
Q2 2020 $1.77M -$541K -23.5% 30 Jun 2020 10-Q 06 Aug 2020
Q1 2020 $1.97M -$490K -19.9% 31 Mar 2020 10-Q 07 May 2020
Q4 2019 $2.13M -$463K -17.9% 31 Dec 2019 10-K 13 Mar 2020
Q3 2019 $2.16M 30 Sep 2019 10-Q 07 Nov 2019
Q2 2019 $2.31M 30 Jun 2019 10-Q 08 Aug 2019
Q1 2019 $2.46M 31 Mar 2019 10-Q 09 May 2019
Q4 2018 $2.59M 31 Dec 2018 10-Q 07 Nov 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.